Real time quantitative PCR as a method to evaluate xenotropic murine leukemia virus removal during pharmaceutical protein purification

Chinese hamster ovary cells used for pharmaceutical protein production express noninfectious retrovirus‐like particles. To assure the safety of pharmaceutical proteins, validation of the ability of manufacturing processes to clear retrovirus‐like particles is required for product registration. Xenotropic murine leukemia virus (X‐MuLV) is often used as a model virus for clearance studies. Traditionally, cell‐based infectivity assay has been the standard virus quantification method. In this article, a real time quantitative PCR (Q‐PCR) method has been developed for X‐MuLV detection/quantification. This method provides accurate and reproducible quantification of X‐MuLV particle RNA (pRNA) over a linear dynamic range of at least 100,000‐fold with a quantification limit of approximately 1.5 pRNA copies μL−1. It is about 100‐fold more sensitive than the cell‐based infectivity assay. High concentrations of protein and cellular DNA present in test samples have been demonstrated to have no impact on X‐MuLV quantification. The X‐MuLV clearance during chromatography and filtration procedures determined by this method is highly comparable with that determined by the cell‐based infectivity assay. X‐MuLV clearance measured by both methods showed that anion exchange chramotography (QSFF) and DV50 viral filtration are robust retrovirual removal steps. In addition, combination of the two methods was able to distinguish the viral removal from inactivation by the Protein A chromatography, and fully recognize the viral clearance capacity of this step. This new method offers significant advantages over cell‐based infectivity assays. It could be used to substitute cell‐based infectivity assays for process validation of viral removal procedures, but not inactivation steps. Its availability should greatly facilitate and reduce the cost of viral clearance evaluations for new biologic product development. © 2004 Wiley Periodicals, Inc.

[1]  D. Livingston,et al.  Mammalian Cells in Culture Frequently Release Type C Viruses , 1973, Science.

[2]  C. Fautz,et al.  Real-time quantitative PCR for retrovirus-like particle quantification in CHO cell culture. , 2000, Biologicals : journal of the International Association of Biological Standardization.

[3]  R. Hepler,et al.  One-step fluorescent probe product-enhanced reverse transcriptase assay. , 1998, BioTechniques.

[4]  J. Vennari,et al.  Detection of minute virus of mice using real time quantitative PCR in assessment of virus clearance during the purification of Mammalian cell substrate derived biotherapeutics. , 2002, Biologicals : journal of the International Association of Biological Standardization.

[5]  R. Abramson,et al.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Payment,et al.  Methods and techniques in virology , 1993 .

[7]  R. Bird,et al.  Development of an improved product enhanced reverse transcriptase assay. , 1997, Journal of virological methods.

[8]  Patrick G. Swann,et al.  Evaluation of a quantitative product-enhanced reverse transcriptase assay to monitor retrovirus in mAb cell-culture. , 2002, Biologicals : journal of the International Association of Biological Standardization.

[9]  Y. Xu,et al.  A real time quantitative PCR-based method for the detection and quantification of simian virus 40. , 1999, Biologicals : journal of the International Association of Biological Standardization.

[10]  Patrick G. Swann,et al.  Use of a Quantitative Product‐Enhanced Reverse Transcriptase Assay to Monitor Retrovirus Levels in mAb Cell‐Culture and Downstream Processing , 2001, Biotechnology progress.

[11]  A. Shepherd,et al.  High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods. , 1999, Journal of virological methods.

[12]  C. Petropoulos,et al.  Chinese hamster ovary cells contain transcriptionally active full-length type C proviruses , 1994, Journal of virology.

[13]  J. Dahlberg,et al.  Structure-specific endonucleolytic cleavage of nucleic acids by eubacterial DNA polymerases. , 1993, Science.

[14]  S. Williams,et al.  Presence and transcription of intracisternal A-particle-related sequences in CHO cells , 1990, Journal of virology.

[15]  Y. Xu,et al.  Real time quantitative PCR as a method to evaluate simian virus 40 removal during pharmaceutical protein purification. , 1999, Biologicals : journal of the International Association of Biological Standardization.

[16]  K. Livak,et al.  Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. , 1995, PCR methods and applications.

[17]  K. Brorson,et al.  Identification of protein A media performance attributes that can be monitored as surrogates for retrovirus clearance during extended re-use. , 2003, Journal of chromatography. A.

[18]  G A Keller,et al.  Endogenous origin of defective retroviruslike particles from a recombinant Chinese hamster ovary cell line. , 1991, Virology.

[19]  J. Böni,et al.  Sensitive detection and quantification of particle‐associated reverse transcriptase in plasma of HIV‐1‐infected individuals by the product‐enhanced reverse transcriptase (PERT) assay , 1996, Journal of medical virology.